148 related articles for article (PubMed ID: 26379984)
1. Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.
Erol MK; Dogan B; Coban DT; Toslak D; Cengiz A; Ozel D
Int J Clin Exp Med; 2015; 8(7):11572-8. PubMed ID: 26379984
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.
Cho HJ; Rhee TK; Kim HS; Han JI; Lee DW; Cho SW; Kim JW
Am J Ophthalmol; 2013 May; 155(5):898-904. PubMed ID: 23385203
[TBL] [Abstract][Full Text] [Related]
3. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
4. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome.
Demirel S; Batioğlu F; Özmert E
J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment.
Zhao C; Zhang Z; Chen L; Wang F; Xu D
Med Sci Monit; 2016 Mar; 22():833-9. PubMed ID: 26972376
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
Shi X; Wei W; Zhang C
Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion.
Dogan E; Sever O; Köklü Çakır B; Celik E
Clin Ophthalmol; 2018; 12():1465-1470. PubMed ID: 30154642
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
Konstantinidis L; Mantel I; Zografos L; Ambresin A
Eur J Ophthalmol; 2010; 20(5):955-8. PubMed ID: 20306440
[TBL] [Abstract][Full Text] [Related]
11. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
12. Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea.
Park YG; Kang S; Roh YJ
Int J Ophthalmol; 2015; 8(2):315-20. PubMed ID: 25938048
[TBL] [Abstract][Full Text] [Related]
13. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
14. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE
Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560
[TBL] [Abstract][Full Text] [Related]
15. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of combined treatments in patients with retinal arterial macroaneurysm.
Wang C; Cao G; Xu X; Wang J; Zhang S
Indian J Ophthalmol; 2021 Dec; 69(12):3564-3569. PubMed ID: 34826996
[TBL] [Abstract][Full Text] [Related]
17. Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.
Kang HM; Lee SJ; Kim CG; Chung EJ; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1681-92. PubMed ID: 26743753
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab for retinal arterial macroaneurysm: long-term results of a prospective study.
Chatziralli I; Maniatea A; Koubouni K; Parikakis E; Mitropoulos P
Eur J Ophthalmol; 2017 Mar; 27(2):215-219. PubMed ID: 27646333
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
[TBL] [Abstract][Full Text] [Related]
20. [Optical Coherence Tomography Angiography-based Follow-up Observation of Wet Age-related Macular Degeneration after Intravitreal Anti-Ranibizumab Therapy].
Yuan MZ; Zhou HY; Chen YX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):359-366. PubMed ID: 31282330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
